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1008Objective: The study was designed to validate euroSCORE II and ACEF (age, creatinine, and ejection fraction)
scores in patients undergoing isolated or associated mitral valve surgery and compare them with logistic euro-
SCORE and Society of Thoracic Surgeons scores.
Methods: Data on 3441 consecutive patients undergoing isolated or associated mitral valve surgery in a 6-year
period were retrieved from 3 prospective institutional databases. Discriminatory power was assessed with the C
index. Calibration was evaluated with calibration curves and associated statistics.
Results: In-hospital mortality was 3.4%. Discriminatory power was uniformly good (for euroSCORE II: area
under curve, 0.79; 95% confidence interval, 0.74-0.84; for logistic euroSCORE: area under the curve, 0.78;
95% confidence interval, 0.74-0.83; for ACEF: area under the curve, 0.73; 95% confidence interval, 0.69-
0.79) but significantly higher in euroSCORE models (P<.05 for Delong, bootstrap, Venkatraman methods).
Calibration pattern was slightly better for the ACEF score, although related summary statistics (unreliability,
Hosmer-Lemeshow test, Spiegelhalter z-test for calibration accuracy) were not significant even for euroSCORE
II. The euroSCORE II demonstrated a performance similar to Society of Thoracic Surgeons score. Logistic euro-
SCORE confirmed the progressive trend toward overprediction previously demonstrated in the general cardiac
surgical population (summary statistics P<.05). Analysis of score performances in the surgical group studied
showed results comparable to the global population.
Conclusions: The euroSCORE II and ACEF scores are good predictors of perioperative mortality in patients
undergoing isolated or associated mitral valve surgery, with better discrimination for the first and better calibra-
tion for the second. No algorithm seems suitable for risk estimation in mid and high-risk patients. (J Thorac Car-
diovasc Surg 2014;147:1008-12)The estimation of perioperative risk has gained an increas-
ingly important role in cardiac surgery, because perioperative
mortality is considered one of the main quality indices of car-
diac surgery. Its prediction can lead to better patient under-
standing of the risks associated with the procedures and
may also aid decision-making behavior of clinicians and
serve as a guide for hospital oversight to allocate resources
efficiently and maximize care for high-risk patients.1 Several
tools have been developed in recent years, and among them
the widest diffusion in the European countries has been
reached by additive and logistic euroSCOREs.2 These algo-
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The Journal of Thoracic and Cardiovascular Surthan adequate in the modern surgical population, with a
high risk of overestimation.3 The lack of performance has
been especially observed invalve surgery subgroups, because
these models were developed and validated in a surgical pop-
ulation composed mainly of those undergoing coronary ar-
tery bypass grafting (CABG).4
To overcome the performance limitations of older euro-
SCOREs, an updated version has been recently released,
with a similar core of risk factors but a different categoriza-
tion of operations.5 Moreover, a new European score, the
ACEF (age, creatinine, and ejection fraction) score, has
been recently developed on the basis of a very limited number
of risk factors.6 Recent validation studies of these new scores
on the general population and the aortic valve surgery sub-
group have been already published; however, no data are
available regarding patients who undergo mitral surgery, a
developing field for new technologies. This study was de-
signed to validate the euroSCORE II and ACEF scores in pa-
tients undergoing isolated and associatedmitral valve surgery
and to compare their performance with those of the logistic
euroSCORE and Society of Thoracic Surgeons (STS) scores.
MATERIALS AND METHODS
The study population included all patients who underwent isolated
or associated mitral valve surgery from January 2006 to April 2012gery c March 2014
Abbreviations and Acronyms
ACEF ¼ age, creatinine, and ejection fraction
AUC ¼ area under the curve
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
STS ¼ Society of Thoracic Surgeons
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D(3441patients enrolled)within the departments of cardiac surgeryof2 univer-
sity hospitals and 1 regional hospital. The study population was extracted
from a larger database that has been updated to April 2012.7 Preoperative
and demographic information, operative data, and perioperative mortality
and complications for all patients were retrieved from the institutional data-
bases, which are prospectively collected. The institutional review boards
approved the data set’s use for research. The institutional ethical committees
approved the study, and the requirement for informed, written consent was
waived on the condition that subjects’ identities remained masked. Data
from the 3 centers were matched and stored in a dedicated data set.
The scores were tested on the prediction of in-hospital mortality. For the
evaluation of the performance, the scores were calculated for each patient
in accordance with published guidelines with a dedicated software. The
STS score can be applied only to isolated mitral surgery and mitral surgery
associated with CABG, so the comparison of the new scores with the STS
score was performed only in these subcategories.
The performance of the scores was analyzed with a focus on discrimina-
tion power and calibration, as previously described.7,8 The discrimination
performance indicates the extent to which the model distinguishes
between patients who will die or survive in the perioperative period.
Discrimination performance was evaluated by constructing receiver
operating characteristic curves for each model and calculating the area
under the curve (AUC) with 95% confidence intervals (CIs). An area of
1.0 indicates perfect discrimination power, whereas an area of 0.5
indicates no discrimination of the binary outcome. The comparison
among curves was analyzed with Delong, bootstrap, and Venkatraman
methods, the first 2 of which compare the AUCs and the last the receiver
operating characteristics curves themselves. Another index used to
evaluate the predictive abilities was the Somers Dxy rank correlation
between predicted probabilities and observed responses. When Dxy ¼ 0,
the model is making a random prediction; when Dxy ¼ 1, the predictions
are perfectly discriminating.
Calibration refers to the agreement between observed outcomes and pre-
dictions, and it was evaluated by generating calibration plots. The perfectly
calibrated predictions stay on the 45 line, whereas curves below and above
the diagonal reflect overestimation and underestimation, respectively. For
each model, the comparison of actual slope and intercept with the ideal
values of 1 and 0 was performed with the U statistic (unreliability test)
and tested against a c2 distribution with 2 df. For testing whether the cali-
bration curve was ideal, we used even the 1-df Spiegelhalter z-test, with its
2-tailed P value for calibration accuracy. Moreover, calibration was tested
with Hosmer-Lemeshow goodness-of-fit test, which compares observed
with predicted values by decile of predicted probability. The accuracy of
the models was also tested by calculating the Brier score (quadratic differ-
ence between predicted probability and observed outcome for each patient),
an overall performance measure that is 0 when the prediction is perfect.
Two-sided statistics were performed with a significance level of 0.05.
For all analyses the R 2.15.1 software was used (R Foundation for Statisti-
cal Computing, Vienna, Austria).RESULTS
The mean age of the group was 66.3  11.8 years, and
44.1% were female. Isolated mitral valve surgery wasThe Journal of Thoracic and Carperformed in 1239 patients (36.0%), 1 associated procedure
was performed in 1461 (42.5%), and 2 or more associated
procedures were performed in 741 (21.5%). CABG was
performed in 1023 patients (29.7%), without other associ-
ated procedures in 613 (17.8%). Other major procedures
included aortic valve surgery in 1036 patients (30.1%),
tricuspid valve surgery in 595 (17.3%), surgery for
ascending aorta in 108 (3.1%), and surgery for left ventric-
ular aneurysm in 71 (2.1%). In-hospital mortality was
3.4% (115 patients). The discriminatory power was good
for all algorithms (for euroSCORE II: AUC, 0.79; 95%
CI, 0.74-0.84; for logistic euroSCORE: AUC, 0.78; 95%
CI, 0.74-0.83; for ACEF: AUC, 0.73; 95% CI, 0.69-0.79)
but significantly higher for the euroSCORE models
(P<.05 for Delong, bootstrap, and Venkatraman methods;
Table 1). The calibration pattern was better for the ACEF
score, with a line closer to the ideal diagonal (Figure 1).
In addition, related summary statistics were more favorable
for the ACEF score, although thy were not significant even
for the euroSCORE II. Logistic euroSCORE confirmed the
progressive trend toward overprediction previously demon-
strated in the general cardiac surgical population (summary
statistics P<.05; Table 1).
The analysis of scores’ performances in isolated and asso-
ciated mitral valve surgery showed comparable results. In
isolated mitral surgery subgroup, the discriminatory power
was significantly superior in STS score and euroSCORE al-
gorithms (for STS: AUC, 0.82; 95%CI, 0.75-0.90; for euro-
SCORE II: AUC, 0.81; 95% CI, 0.75-0.88; for logistic
euroSCORE: AUC, 0.82; 95% CI, 0.76-0.89; for ACEF:
AUC, 0.76; 95% CI, 0.68-0.83; P<.05 for all comparisons
between ACEF and other scores andP>.05 for comparisons
between STS and euroSCOREs). In associated mitral valve
surgery, the superiority of discriminatory performance of
euroSCORE models was less marked and not significant
(for euroSCORE II: AUC, 0.75; 95% CI, 0.69-0.82; for lo-
gistic euroSCORE: AUC, 0.70; 95% CI, 0.67-0.80; for
ACEF: AUC, 0.70; 95% CI, 0.64-0.77; P>.05 for all com-
parisons). In patients who underwent mitral surgery associ-
ated with CABG, the STS score but not euroSCOREs
demonstrated a significantly higher discrimination power
relative to the ACEF score (for STS score: AUC, 0.76;
95% CI, 0.65-0.88; for euroSCORE II: AUC, 0.74; 95%
CI, 0.61-0.86; for logistic euroSCORE: AUC, 0.73; 95%
CI, 0.60-0.85; for ACEF: AUC, 0.70; 95% CI, 0.56-0.80;
P<.05 for all comparisons between ACEF and STS score
and P> .05 for all comparisons between STS and euro-
SCOREs and between euroSCOREs and ACEF).
The pattern of calibration was similar for all scores in the
2 subgroups. Logistic euroSCORE showed a tendency to-
ward progressive overprediction, which was confirmed
even by the associated summary statistics that were signifi-
cant (P< .0001 for unreliability test, Hosmer-Lemeshow
test, and Spiegelhalter z-test in both isolated and associateddiovascular Surgery c Volume 147, Number 3 1009
TABLE 1. Performance of the logistic euroSCORE, euroSCORE II, and ACEF scores in predicting in-hospital mortality among patients
undergoing isolated or associated mitral surgery
Logistic ES ES II ACEF score
Predicted mortality 8.4  9.7 3.8  5.3 3.2  3.9
First quartile (25%) 2.8 1.2 1.5
Median value 5.3 2.3 1.9
Third quartile (75%) 10.0 4.3 3.1
Overall performance
Brier score 0.03 0.03 0.03
Discrimination
AUC (95% CI) 0.78 (0.74-0.83) 0.79 (0.74-0.84) 0.73 (0.69-0.79)
DeLong test P value
Versus ACEF .02* .01* —
Versus ES II .58 — —
Bootstrap method P value
Versus ACEF .02* .01* —
Versus ES II .57 — —
Venkatraman P value
Versus ACEF .04* .02* —
Versus ES II .80 — —
Somers Dxy .57 .58 .47
Calibration
U statistic P value .00* .14 .80
Hosmer-Lemeshow test P value .00* .06 .73
Spiegelhalter z-test .00* .10 .45
Best performance for Brier score ¼ 0, area under the curve¼ 1, Somers Dxy ¼ 1, nonsignificant P values (P>.05) of the U statistic, Hosmer-Lemeshow test, and Spiegelhalter
z-test. ES, euroSCORE; ACEF, age, creatinine, and ejection fraction; AUC, area under the curve; CI, confidence interval. *P<.05.
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Dmitral surgery). On the contrary, even in the subgroups the
summary statistics were not significant for euroSCORE II
and ACEF scores, although the ACEF score showed a
more constant plot with a slight overprediction. In isolated
mitral valve surgery and mitral surgery associated with
CABG, the STS score demonstrated a calibration pattern
similar to that of the euroSCORE II, with nonsignificant
associated statistics (isolated mitral surgery unreliability
test P ¼ .47, Hosmer-Lemeshow test P ¼ .25, and Spiegel-
halter z-testP¼ .47; mitral surgery plus CABG unreliability
test P ¼ .06, Hosmer-Lemeshow test P ¼ .06, and Spiegel-
halter z-test P ¼ .06). In all scores, a tendency toward over
miscalibration was evident after 20% predicted mortality.
Discrimination and calibration of the scores were also
tested in patients who underwent elective mitral surgery,
because the ACEF score was developed in a nonurgent
setting, without finding significant differences with the per-
formance of the scores applied to the entire study group.
AUC of ACEF score in elective mitral surgery was 0.71
(95% CI 0.65-0.77), significantly lower than that of the
euroSCORE II and logistic euroSCORE. Even the patterns
of calibration plots and the associated statistics were similar
when applied to elective surgery and the total population.
DISCUSSION
The main limitation of the older logistic euroSCOREwas
confirmed, even in the subgroup of patients who underwent
mitral valve surgery, with the tendency toward progressive1010 The Journal of Thoracic and Cardiovascular Suroverprediction evident for both associated and isolated
mitral operations and similar to that shown for the general
population.7 The calibration analysis demonstrated that
both the euroSCORE II and ACEF scores have ameliorated
the performances of the logistic euroSCORE, as confirmed
by the summary statistics. Nonetheless, the patterns of cali-
bration were different. Both scores demonstrated an optimal
calibration until 20% predicted mortality, at which point
the plots diverged significantly. The ACEF score in the
higher risk showed a better accuracy, with its calibration
line closer to the ideal diagonal, although a constant over-
prediction was still present. The euroSCORE II appeared
less calibrated in the higher risk group, with a large fluctu-
ation around the ideal line, and its calibration pattern was
similar to that of the STS score in the subgroups for which
the latter could be calculated. On the other side, the discrim-
inatory power was higher for the logistic euroSCORE and
euroSCORE II, as well as for the STS score, and this
outcome is in contrast with previous studies. The ACEF
score was previously demonstrated by internal validation
to have better global performance than more complex mor-
tality scores, and even a large external validation study
demonstrated that the ACEF score has noninferior accuracy
and better clinical performance with respect to the additive
and logistic euroSCORE.9
Risk estimation in cardiac surgery is an evolving issue.
Several questions have not been yet addressed, and new
advances in techniques and perioperative care are movinggery c March 2014
FIGURE 1. Performance evaluation of the ACEF (age, creatinine, and ejection fraction) score, euroSCORE II, and logistic euroSCORE in patients who
underwent associated/isolated mitral surgery. A, Receiver operating characteristic curves for the models. B, Calibration plots of the scores are analyzed by
means of smooth nonparametric fit with locally weighted scatterplot smoothing. The diagonal lines represent the ideal calibrations.
Barili et al Acquired Cardiovascular Disease
A
C
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subgroups of patients. The screening and selection of
high-risk patients eligible for new surgical techniques,
such as transcatheter aortic valve implantation and Mitra-
Clip, has underlined a tendency to overpredict the risk of
mortality of older euroSCOREs and led to new validation
studies confirming the miscalibration.4 The lack of calibra-
tion of the additive and logistic euroSCOREs has been
attributed to the changing epidemiology of cardiac surgery
and the nonhomogeneity between the surgical population
used to developed the scores and the study groups to which
the scores are applied. The new scores have been demon-
strated to have better performances in the general surgical
population,7 and the outcomes of this study confirmed this
tendency even for the subgroup of patients who underwent
isolated or associated mitral valve surgery. Nonetheless, a
common limitation of both the euroSCORE II and ACEF
scores remains the tendency toward miscalibration in
high-risk deciles. Even in this case, the original study pop-
ulation was mainly composed of those undergoing CABG,
and the quota of high-risk patients was small. The use of
these scores for the selection of high-risk patients in a spe-
cific surgical subgroup thus can lead to lower calibration
performance. The suboptimal predictor power in specific
subgroups has been already been demonstrated for the
STS score as well, even though previous studies have shown
that it outperforms the logistic euroSCORE10 as it was
developed in a larger population and the valvular subgroups
are more represented. Nonetheless, the low number of pa-
tients with a predicted mortality higher than 15% leads
one to consider cautiously the smooth nonparametric fitted
calibration curves in the high-risk patients, because a
greater number of higher-risk subjects are requested to
obtain more precise estimates, and thus an analysis of score
performance in large high-risk patients registries, such as
transcatheter valve registries, is necessary to validate euro-
SCORE II and ACEF scores in high-risk deciles and to
confirm the potential miscalibration. Large high-risk groups
are also needed to evaluate the role of comorbidities notThe Journal of Thoracic and Carincluded in the current score algorithms, such as porcelain
aorta, frailty, oxygen-dependent chronic obstructive pulmo-
nary disease, and chest wall deformity. Their inclusion in
the models could lead to new dedicated scores that have
been already claimed to overcome the potential limitations
of existing tools.
Limitations
The potential limitation of the study is its retrospective
nature. Data were derived from three institutional data
sets that were prospectively collected. In all data sets, orig-
inal euroSCORE factors were collected in specific columns
together with the scores’ values; the logistic euroSCORE
for each patient was therefore computed again to check
the correctness of the values. The new factors of the euro-
SCORE II and ACEF scores were derived from the data
sets, creatinine clearance was computed as suggested, and
categorizations were recalculated from continuous data.
Nonetheless, the retrospective nature of scores’ calculus
can lead to biases if compared with the prospective deriva-
tion of the original versions, whose factors were specifically
and prospectively collected. Another main limitation of the
study is the relative sample size of the study group.
Although we collected data from more than 3400 patients
who underwent mitral surgery, mortality was 3.4%, with
only 115 events, and our results should therefore be
confirmed in larger data sets with higher numbers of events.
Moreover, 95% of the sample had a predicted mortality
lower than 15% for both scores, whereas few patients in
our study group were at high risk. The pattern of the calibra-
tion curves after the first 2 deciles should therefore be
confirmed in a high-risk population. Even performance
analysis in etiologic subgroups was not possible because
of the low number of events.
CONCLUSIONS
The euroSCORE II and ACEF scores are good predictors
of perioperative mortality in patients undergoing isolated or
associated mitral valve surgery, with a better discriminationdiovascular Surgery c Volume 147, Number 3 1011
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Dfor the first and a better calibration for the second. Neither
of these algorithms seems suitable for risk estimation in mid
and high-risk patients.References
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